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3a-Hydroxystcroid dchydrogenasc (3a-HSD) from f?~domor~~s re roslerurri was shown to reduce the xenobiotic arbonyl compound mctyrapone 
(MPON). Revcrscly, MPON reductase purified from mouse liver microsomcs and previously characterized asaldehyde rcductase, was competitively 
inhibited by 3o-HSD steroid substrates. For MPON reduction both enzymes can use either NADH or NADPH as co-substrate. lmmunoblot 
analysis alter native and SDS gel eleclrophoresis of 31x-HSD gave a specific rossreaction with the antibodies against he microsomal mouse liver 
MPON reductase pointing to structural homologies bctwtin these nzymes. In conclusion, there seem to exist structural as well as functional 
relationships between a mammalian liver aldehyde reductase and prokaryotic 3a-HSD. Moreover, based on the molecular weights and the 
co-substrate specificities microsomal mouse liver MPON reductose and Pseudomonas 30.HSD seem to be members of the short-chain alcohol 
dehydrogenase fumily. 
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1. INTRODUCTION 
Carbonyl reducing enzymes constitute the enzyme 
family of the aldo-keto reductases, which catalyze the 
reduction of carbonyl group bearing substrates to the 
corresponding alcohols. They are distributed in various 
mammalian and non-mammalian tissues and share typi- 
cal features uch as monomeric structure in the molec- 
ular weight region between 30110 kDa, almost exclusive 
dependence on NADPH as co-substrate and cytosolic 
subcellular localization [3,4]. They have been originally 
referred to as carbonyl reductase and metabolize a 
broad spectrum of exogenous carbonyl compounds, in- 
cluding aliphatic and aromatic aldehydes and ketones, 
where they obviously play an important role in de- 
‘Although reclassified as ‘Co~namorras ~esrosreroni’ [I], the original 
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toxiflcation processes. Furthermore, enzymes like 
NAD(P)H: quinone-oxidoreductase (NQR EC 
1.6.99.2), dihydrodiol dehydrogenase (DDH, EC 
1.3.1.20), and hydroxystcroid ehydrogenases might be 
involved in carbonyl metabolism. In addition to their 
contribution to the detoxification process carbonyl 
reductases participate in the reductive metabolism of a 
great variety of physiologically occurring endogenous 
substrates and were shown to catalyze the carbonyl 
reduction of prostaglandins [5,6], biogenic amines [7] 
and steroid hormones [S-10]. However, their phy- 
siological role is not fully understood and remains to be 
determined. 
We use the ketone metyrapone (MPON), the potent 
cytochrome P-450 inhibitor, as a substrate to investigate 
carbonyl reducing enzymes. In previous studies we 
purified and characterized a MPON reducing enzyme 
from mouse liver microsomes and demonstrated that 
this enzyme belongs to the aldo-keto reductase family 
[l 11. Differing from common characteristics of this en- 
zyme family the MPON reductase from mouse liver 
microsomes has the ability of utilizing both NADPH 
and/or NADH as co-substrates and is localized in the 
endoplasmic reticulum of the cell. Moreover, although 
reducing a ketone, the enzyme was characterized as an 
aldehyde reductase due to its sensitivity to the diagnos- 
tic inhibitor phenobarbitai (4 and acc&ing *10 the in- 
hibitor classification of the aldo-keto reductases. 
In this study the possible physiological function of the 
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liver microsomal MPON reductase was of interest, in 
order to promote the understanding of the physiological 
role of the aldo-keto reductases. The potentiality of dual 
co-substrate utilization and the ability of Sa-dihydrotes- 
tosterone to competitively inhibit MPON reduction 
suggest his enzyme to be related to 3a-hydroxysteroid 
dehydrogenase (3a-HSD) [l 11. Therefore, to investigate 
functional similarities between these two enzymes, we 
tested 3~HSD from Pseudomonas testosreroni for its 
ability to reduce MPON. Reversely, MPON reductase 
from mouse liver microsames was tested for its sensiti- 
vity to steroid substrates of 3a-HSD, such as testoste- 
rone, Sa-dihydrotestosterone, 5,&dihydrotestosterone, 
progesterone, androstandione and androsterone, re- 
spectively for its ability to catalyze the oxidoreduction 
of these compounds. Furthermore, in order to obtain 
information about immunological and thus structural 
homologies between 3a-HSD and MPON reductase, we 
checked antibodies against he microsomal mouse liver 
enzyme for crossreactivity with the Pswdontonas pro- 
tein. 
2. MATERIALS AND METHODS 
2,l. Animals 
Livers of female NMRI mice were used throughout the study. k- 
hydroxysteroid ehydrogenase (3a-HSD) from Pseudotnonns tcstos- 
reroni was purchasbd from Bochringcr Mannheim (Mannheim, 
Germany) (Lot N”. 10691627-01) or Sigma (Deisenhofen, Germany) 
(Grade II; No. 79c-6820). 
2.2, Cftemtcafs 
NADH. NADPH, G-Ci-Pand G-6-P-DH were obtained from Boeh- 
ringer Mannheim (Mannheim, Germany). For HPLC acetonitrile of 
HPLC-grade from E. Merck (Darrnstadt, Germany) was used. Low 
molecular weight markers were obtained from BioRad (Munich, 
Germany), SDS from Fluka (Buchs. Switzerland), acrylamide, 
methylencbisacrylamidc, 4-chloro-1-naphthol and H+& from E. 
Merck (Darmstadt. Germany), nitrocellulose from Schleicher and 
Schuell (Dassel, Germany), testosterone, androswone, andro- 
standione, progesterone, Srxmdihydrotestosterone. $&dihydrotestos- 
terone, Meldola blue @dimethyl-?, benzophenoxazin), p-iodotetra- 
nitrozolium from Sigma (Deisenhofen, Germany), and peroxidase- 
conjugated anti-rabbit IgG antibodies from Dakopstts (Hamburg, 
Germany). All other chemicals used in the experiments were reagent 
grade and were obtained by commercial suppliers. 
2.3. Atrificuriott o/the tnicrosotnaf MPON reductase 
Purification of the microsomal MPON reductase for enzymatic 
assays and for immunization was performed as described elsewhere 
[l1,12]. 
2.4. Itnntttni:aarion and preparation of anrisera 
I mg of the enzyme preparation was dissolved in 62.5 mM Tris-HCI, 
0.1% (w/v) SDS, 0.5 mM EDTA, pH 6.8 and emulsified with I Vol. 
complete Freund’s adjuvant. For immunization, a female rabbit was 
injected subcutaneously (0.9 ml emulsion containing about 0.3 mg 
protein (2 x) or 0.2 mg protein (2 x) per injection) four times on the 
following days: I, 3, 5 and 36, the latter being the booster. 
2.5. SDS-polyucryfatnidr grf elccrrophoresis (SDS-PAGE), efec- 
rroclurion und itntnrmobfotthtg 
SDS-PAGE [13], clectroelution ofproteins [14] and immunoblotting 
[lr] were performed as described previously [12]. 
2.6. Narive gel cfccrropltorcsis 
Native gel electrophoresis was carried out as described under SDS- 
PAGE, but SDS was omitted. Gels were run at 4’C with 185 V 
constant voltage. 
2.7. Activity stabtfng 0JIer native gel efecrropftorestk 
(A) 301.HSD activity was detected by incubating the gel slices in a 
solution containing I.5 mM NAD’. 0.5 mM androsterone (dissolved 
in methanol), 0.05 mM Meldola blue @dimethyl-2.3 bnzopheno- 
xazin) and 0.31 mM p&donitrotetrazolium. Enzymatically active pro- 
tein bands arc seen as purple formazan bands. 
(Et) MPON reducing activity was detected by preincubadng the gel 
slices for 30 min in a solution containing 1.5 mM NADH, 1.5 mM 
NADPH and 2.3 mM MPGN. Visualization of MPON reducing en- 
zymes was performed by incubation in a solution containing 0.05 mM 
Meldola blue. 10 mM sodium ohosohate buffer. DH 7.4. and 0.31 mM 
p-iodonitrote&olium. Enzyhati&lly active protein dands are seen 
as transparent bands against a purple background. 
2.8. intmuttobfor after native gel rfecrrophoresis 
Gel slices were incubated for 30-60 min in a solution containing 375 
mM TrislHCl, pH 8.8, and 0.5% SDS and blotted for 2 h in a semidry 
apparatus according to Kysc-Anderson (151. 
2.9. En:ynre assays 
Assay of MPON reduction and subsequent reduced metabolite 
detection by HPLC was performed as described previously [I 21. 
2.10. Protein derenninarfon 
Protein concentration was determined by the method of Lowry et 
al. [16]. 
3. RESULTS 
3.1. MPON reduction by 3a-HSD 
As can be seen in Table 1 the Pseudomoms 3a-HSD 
preparation has the ability of reducing the xenobiotic 
carbonyl compound MPON to the respective alcohol 
metabolite metyrapol (MPOL). Compared to the mouse 
liver enzyme V,, values are almost similar, but K,,, 
values differ considerably: whereas IMPOL formation 
by mouse liver MPON reductase has a much lower K, 
with NADPH than NADH as co-substrate, that of 3a- 
HSD is slightly lower with NADH. This corresponds to 
other reports, which demonstrate that 3a-HSD of Pseu- 
domonas testosteroni in principle is dependent on 
Table I 
Reduction of MPON by 3a.hydroxysteroid dehydrogenase (3n-HSD) 
from Psctrdotnonas resrosreroni and MPON reduc~x from mouse 
liver microsomes. 
Enzyme Co-substmte 
ccl%, 
V 
(nmoUm~~0 min) 
MPON reductase NADH 4.77 347.t3 
NADPH 0.22 211.35 
3a-HSD NADH 0.56 352.65 
NADPH 0.64 314.60 
Enzyme activities were assayed in the standard reaction mixture con- 
taining 50 mM sodium phosphate buffer, pH 7.4, h@DN conanux- 
lions between 0.05-3.2 mM and either 3.2 mM NADH or 3.2 mM 
NADPH, respectively. Reduced metabolite detection wus performed 
by HPLC analysis. 
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Table II 
Inhibition of MPON reduction by steroid substrates of 3a-HSD, 
Steroid substrate Residual activity 
(8) 
Testosterone 23.2 
Androstandione 30.4 
Progcstcrone 35.0 
S@Dihydrotestosterone 39.4 
Sa-Dihydrotestosterone 41.3 
Androsterone 56.6 
Enzyme activities were assayed in the standard reaction mixture con- 
taining 50 mM sodium phosphate buffer, pH 7.4, 0.5 mM MPON, a 
NADPH-rcgcnerating system and 0.5 mM of the respective inhibitor. 
The percentages were calculated from uninhibited control expcri- 
mcnts. Control velocities were determined in the presence ofappropri. 
ate quantities of the solvents. Reduced metabolite detection was per- 
formed by HPLC analysis. 
NADH rather than on NADPH as electron donor [17- 
191. 1 2 3 4 
3.2. inhibition of MPON redrwase by steroids 
As shown in Table II, purified MPON reductase from 
mouse liver microsomes is strongly inhibited by steroid 
substrates of 3a-HSD, such as androsterone, testos- 
terone, $3.DHT, Sa-DHT, progesterone and andro- 
standione. The competitive nature of this inhibition (de- 
termined for the latter three compounds) gives rise to 
the suggestion that steroids are physiological substrates 
of this enzyme. But when tested, neither of these sub- 
stances was metabolized by microsomal MPON 
reductase, as indicated by TLC, HPLC or indirect spec- 
Imnunablot SDS-PAGE 
kDa 
kDa 
- 92.5 
- 66.2 
- 45.0 
- 31.0 
- 21.5 
- 92.5 
- 66.2 
- 21.5 
Fig. I. SDS-PAGE and immcr?ob!ot of 3+hydrorysteroid ehy 
drogenase (3a-HSD) from Pre~tdomonas rc rosraroni. The antibody 
against the microsomal mouse liver mctyraponc reductase 
crossreacted speciRcally with the 3a-HSD in the 28 kDa molecular 
weight repion. For details see section 2. 
Fig, 2. Activity staining of 3a-hydroxysteroid dehydrogenase (3a- 
HSD) from Pseudor~ronas testosteroni alter native gel electrophoresis. 
Lane I. Coomassic stained protein pattern of the 3tz-HSD prepara- 
tion; lane 2, androsteronc oxidating activity of 30.HSD, lane 3, mcty- 
raponc reducing activity of 3rr-HSD; lane 4, inimunoblot of 3a-HSD 
after native gel clectrophoresis u ing the antibody against he micro- 
somal mouse liver mstyrapone reductase, For details ee section 2. 
trophotometric recording of pyridine nucleotide oxido- 
reduction. 
3.3. Inwzu~tochemicai unalysis of 3ol-ffSD 
Fig. 1 shows that the polyclonal antibodies against 
the microsomal mouse liver reductase also crossreacted 
specifically with the Pseudonnonas 3a-I-ED in the 28 
kDa molecular weight region [l71, indicating the pres- 
ence of common antigenic determinants. Fig;. 1 also 
reveals that the commercially available 3a-HSD 
preparation of Pseudomonas testosreroni still consists of 
a complex pattern of protein bands. 
3.4. Native gel electrophoresis and activity staining of 
Ja-HSD 
To demonstrate that the 28 kDa band is associated 
with the 3u-HSD activity and that the same band also 
represents the MPON reducing activity native gel elec- 
trophoresis (NGE) and subsequent activity staining 
were performed. Fig. 2 shows in the first lane the 
Coomassie stained protein pattern of 3a-HSD prepara- 
tion of Pseudomonas testosteroni after NGE. The 
steroid dehydrogenase activity in the gel slice was de- 
tected using androsterone as substrate [17] which is 
oxidized at the 3a-OH group of Zing A of ihie SiXOid 
molecule and which results in a group of three purple 
bands of lane 2. Lane 3 shows a gel slice of the same 
enzyme preparation, but was incubated with MPON as 
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substrate, which is reduced at its ketone function to the 
corresponding alcohol metabolite MPOL. Activity 
staining revealed a broad transparent band against a 
purple background in the same region, representing the 
carbonyl reducing activity of the dehydrogenase. The 
two corresponding enzyme activities within the same 
protein band indicate that fa-HSD from Pseudomonas 
tesfosterom is capable of oxidizing androsterone as well 
as reducing the ketone MPON. 
3.5. Immunoblorting after NGE 
Immunoblotting after NGE of the Pseudomoltas de- 
hydrogenasc with the antibody against he mouse liver 
enzyme gave a positive crossreaction i the same region 
(Fig. 2) verifying the suggestion that there exist struc- 
tural homologies between the MPON reductase from 
mouse liver microsomes and the 3a-HSD from Pseudo- 
monas testosterorzi, which indicates a possible rela- 
tionship between these enzymes. 
The identity of this enzyme with 3a-HSD was proved 
again by cutting out the respective protein band of the 
native gel and subjecting itto electroelution followed by 
SDS-PAGE and subsequent immunological charac- 
terization. Corresponding to the results of Fig. 1 SDS- 
PAGE revealed aprotein band in the 28 kDa molecular 
weight region, which was immunoreactive to the anti- 
bodies against he mouse liver enzyme (data not shown). 
In some immunoblot experiments after NGE of 3a- 
HSD an additional band of crossreaction was observed 
in the higher molecular weight region, but no band of 
activity, neither with androsterone nor with MPON as 
a substrate, could be observed in this region. This cor- 
responds to Skllhegg [20] who provided evidence that 
3a-HSD of Pseudomonas restosreroni exhibits reversible 
concentration-dependent monomer-dimer transitions, 
which resulted in a 90% reduction of specific activity in 
the case with androsterone as substrate. After lowering 
the protein concentration i  the solution for NGE the 
higher molecular weight band after immunoblotting 
could not be detected in our experiments, probably due 
to the dissociation of the dimers into the active mo- 
nomers. 
As described already by Shikita and Talalay [17], the 
3a-HSD of Pseudomonas testosreroni resides in two 
major and one minor catalytic activities after NGE, 
which corresponds to the present results with andro- 
sterone as substrate for oxidation (Fig. 2). However, 
this hint to the existence of various isozymes could not 
be supported with MPON as substrate for carbonyl 
reduction, which might be due to methodological 
problems (diffusion of pyridine nucleotides during the 
preincubation period: cf. section 2). 
4. DISCUSSION 
The present studies have demonstrated that 3a-HSD 
from Pseudomonas restosteroni and MPON reductase 
from mouse liver microsomes on the one hand share 
similar functional properties in that both are able to 
catalyze MPON reduction, respectively that steroid 
substrates of 3cc-HSD proved to be strong and competi- 
tive inhibitors of the mammalian liver enzyme. In addi- 
tion, both show dual co-substrate specificity for NADH 
or NADPH. On the other hand, MPON reductase and 
3a-HSD seem to be structurally related ue to the anti- 
genie crossreaction i immunoblot experiments. 
The characterization of aldo-keto reductases often 
revealed that former classifications based on functional 
data do not always correspond to phylogenetic las- 
sifications based on structural data. In contrast, despite 
lacking enzyme properties ome proteins could be clas- 
sified as members of respective oxidoreductase families. 
In general, the following superfamilies can be distin- 
guished: (1) aldo-keto reductases comprising human 
liver aldehyde reductase, human placenta aldose 
reductase, rat lens aldose reductase [2 1,221, Z,Sdiketo- 
gluconic acid reductase [23j, prostaglandin F synthetase 
[24], and frog p-crystallin [25]; (2) short-chain alcohol 
dehydrogenases comprising 17/I-hydroxysteroid dehy- 
drogenase, IS-hydroxyprostaglandin dehydrogenase, 
Nod G protein of Rhkobium rnelilolii [26] and 3p- 
hydroxysteroid dehydrogenase from Pseudomonas 
testosteroni [27]; (3) NAD(P):quinone oxidoreductase, 
hitherto the sole member of this family. 
For a considerable number of carbonyl reducing en- 
zymes the classification to one of these families is un- 
known. We propose a relationship of the enzymes in- 
vestigated in this study to the family of short chain 
alcohol dehydrogenases, based on the low molecular 
weights (28 kDa for 3a-HSD from Pseudomonas testos- 
teroni and 34 kDa for MPON reductase from mouse 
liver microsomes) and their co-substrate specificities. 
In summary, besides exhibiting structural as well as 
functional relationships microsomal mouse liver 
MPON reductase and Pseudomonas 3a-HSD possibly 
belong to the short-chain alcohol dehydrogenase upcr- 
family. 
Ac~~~o~~~Ld~etnenrs: The skillful technical assistance of J. 
Friebcrtshtluser and I. Bohl is gratefully acknowledged. The study 
contains parts of the work of the dissertation of U. Opprmann. 
REFERENCES 
[l] Tamaoka, J., Ha, D.-M. and Kamagata. K. (1987) Int. J. Syst. 
Bactcriol 37, 52-59. 
[2] Marcus, P. and Talalay, P. (19%) J. Biol. Chcm. 218,661-674. 
[3] Wcrmuth, B., in: Enzymology of Cnrbonyl Metabolism: Al- 
dehydc Dchydropenase, Aldo/Keto Rcductase, and Alcohol De- 
hydrogcnase (Flynn, T.G. and Weiner. H., Eds.) 2nd edn., Liss, 
New York, 1985, pp. 209-230. 
[4] F&ted. R.L. and Bachur, N. (1980) Drug Metab. Rev. 11. l-60. 
[5] Hayashi. H., Fujii, Y., Watanabe, K., Umde, Y. and Hayaishi, 
0.. in: Enzymology and Molecular Biology of Carbonyl Met&o- 
lism 2 (Weiner, H. and Flynn, T.G., Eds.) Lisa, New York, 1989, 
pp. 365-379. 
199 
Volume 297, number I,2 FEBSLE’ZTERS February 1992 
[6] Iwata, N., Inazu, N. and Satoh, T. (1990) J. Biochem, 107, 209- [IB] Groman, E.V. and Enpel, L,L, (1977) Biochim. Biophys. Ac~a 
212. 485, 249-254. 
[7] Smolcn, A. and Anderson, A.D. (1976) Biochem. Pharmacol. 25, 
317-323. 
[II)] Aukrust, L.E., Norum, K.R. and SkBlhegg, B.A. (1976) Biochim. 
Biophys. Acta 438; 13-22. 
[8] Pietruszko, R. and Chen, F.F. (1976) Biochcm. Pharmacol. 25. 
2721-2725. 
[9] Sawada, H., Ham. A., Hayashibara, M. and Nakayama, T. 
(1979) J. Biochem. 86,883-892. 
[IO] Ikeda, M., Hattori, H, and Ohmori, S. (1984) Biochem. Phar- 
macol. 33. 3957-3961. 
[20] SkBlhegS,. B A. (1974) Eur. J. B&hem. 46, 117-125. 
[?I] Bohren, K.M., Bullock, B,, Wermuth, B. and Gabbay, K.H. 
(1989) J. Biol. Chcm. 264, 9547-9551. 
[22] Wermuth, B., Omar, A., Forster. A., di Francesco, C., Wolf, M., 
von Wartburg, J,-P., Bullock, B. nnd Gabbay, K.H. (1987) Prog. 
Clin. Biol. Res. 232, 297-307. 
[I I] Maser, E. and Netter, K.J.( 1989) Biochem. Pharmacol. 38,3049- 
3054. 
1121 Maser, E. and Netter, K.J.(1991) Biochem. Pharmacol.41, 595- 
[23] Anderson, S., Marks, C.B., Lazarus, R,, Miller, J., Stafford, K., 
Seymour, J., Light, D., Rastetter. W. and Estell. D. (1985) Science 
230, 144-149. _ _ 
1599. 
[13] Laemmli, U.K. (1970) Nature 227,680-685. 
[14] Gerton, GL,. Wardrip, NJ. and Hedrick, J.L. (1982) Anal. 
Biochem. 126, 116121. 
[I51 Kyhse-Anderson. J (1984) J. B&hem. Biophys. Methods 10, 
203-209. 
[16] Lowry, O.H.. Rosebrough. N.J.. Farr. A.L. and Randall, R.J. 
(1951) J. Biol. Chem. 193, 265-275, 
[17] Shikita, M. and Talalay. P. (1979) Anal; Biochem. 95, 278-292. 
[24] Watanabe, K., Fujii, Y,, Nakayama, K., Ohkubo, H., Ku- 
ramitsu, S.. Kagatniyama, H., Nakanishi, S. and Hayaishi, 0. 
(1988) Proc, Natl. Acad. Sci. USA 85, I I-15. 
[25] Tomarev. S.I., Zinovieva, R.D., Dolgilevich, SM., Luchin, S.V., 
Krayev, A.S., Skryabin, K.G. and Gause, G.G. (1984) FEDS 
Lett. 171, 297-302. 
[26] Baker, ME. (1989) Mol. Endocrinol. 3, 881.884. 
[27] Yin, S.J., Vagelopoulos, N., Lundquist, G. and Jt)rnvall, H. 
(1991) Eur. J. Biochem. 197, 359-365. 
200 
